http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021507803-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2210-0004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2210-0612
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0039
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-0004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0031
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00781
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M27-002
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
filingDate 2018-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2021507803-A
titleOfInvention Implant device for eye diseases for regulation of intraocular pressure
abstract The present invention relates to an eye disease implant device for adjusting eye pressure, and the eye disease implant device for adjusting eye pressure according to an embodiment of the present invention is an ocular chamber for adjusting eye pressure. It includes a first tube into which water flows in and a second tube formed inside the first tube, the second tube being inserted into the eye and then the eye over time. The first and second tubes are made of biodegradable material that is decomposed in the eye, and can be divided into a first region and a second region according to the distance from the anterior chamber of the eyeball. The second region of the first tube and the second tube has a larger diameter than the first region of the first tube and the second tube, and may have a structure that can be expanded by the inflow of atrioventricular water. [Selection diagram] Fig. 1
priorityDate 2017-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017156530-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014343476-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962

Total number of triples: 20.